Duyuru • Apr 23
Rayonier Advanced Materials Inc. to Report Q1, 2026 Results on May 05, 2026 Rayonier Advanced Materials Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 05, 2026 Duyuru • Apr 07
Rayonier Advanced Materials Inc. Resumes Operations at Jesup Facility After Fire Incident Rayonier Advanced Materials Inc. confirmed that an isolated fire occurred at approximately 10:00 p.m. on April 4 in the digester area of its Jesup, Georgia facility during its scheduled annual maintenance outage. The fire was quickly contained and extinguished by the Company’s on-site team with assistance from local first responders. There were no injuries and no off-site impacts. The Company has initiated standard follow-up actions, including a root cause investigation and repair planning. Jesup is resuming operations following the outage, with one production line currently not operating due to the fire. The Company continues to assess operational impacts but does not currently anticipate any material impact to its ability to timely supply customers in line with commitments. Duyuru • Mar 24
Rayonier Advanced Materials Inc., Annual General Meeting, May 13, 2026 Rayonier Advanced Materials Inc., Annual General Meeting, May 13, 2026. Location: 1301 riverplace boulevard, 22nd floor, jacksonville, florida, United States Recent Insider Transactions Derivative • Mar 06
CFO & Senior VP of Finance exercised options and sold US$92k worth of stock On the 1st of March, Marcus Moeltner exercised options to acquire 10k shares at no cost and sold these for an average price of US$9.47 per share. This trade did not impact their existing holding. Since March 2025, Marcus' direct individual holding has increased from 172.14k shares to 187.42k. Company insiders have collectively bought US$225k more than they sold, via options and on-market transactions, in the last 12 months. Reported Earnings • Mar 04
Full year 2025 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2025 results: US$6.33 loss per share (further deteriorated from US$0.64 loss in FY 2024). Revenue: US$1.47b (down 10% from FY 2024). Net loss: US$423.0m (loss widened US$381.0m from FY 2024). Revenue exceeded analyst estimates by 3.8%. Earnings per share (EPS) missed analyst estimates by 3.4%. Revenue is forecast to grow 5.1% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 107 percentage points per year, which is a significant difference in performance. New Risk • Feb 26
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 15% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-US$80m). Share price has been volatile over the past 3 months (15% average weekly change). Duyuru • Feb 19
Rayonier Advanced Materials Inc. to Report Q4, 2025 Results on Mar 03, 2026 Rayonier Advanced Materials Inc. announced that they will report Q4, 2025 results at 4:00 PM, US Eastern Standard Time on Mar 03, 2026 Duyuru • Jan 13
Rayonier Advanced Materials Inc. Announces Departure of Joshua Hicks as Senior Vice President, High Purity Cellulose, Effective January 11, 2026 Rayonier Advanced Materials Inc. On January 11, 2026, Joshua Hicks, Senior Vice President, High Purity Cellulose, separated from Rayonier Advanced Materials Inc., effective January 11, 2026. The High Purity Cellulose organization will report to Scott Sutton, President and Chief Executive Officer. Reported Earnings • Nov 06
Third quarter 2025 earnings: EPS in line with expectations, revenues disappoint Third quarter 2025 results: US$0.06 loss per share (improved from US$0.49 loss in 3Q 2024). Revenue: US$353.0m (down 12% from 3Q 2024). Net loss: US$4.00m (loss narrowed 88% from 3Q 2024). Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance. New Risk • Nov 06
New major risk - Revenue and earnings growth Earnings have declined by 38% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.3x net interest cover). Earnings have declined by 38% per year over the past 5 years. Duyuru • Oct 22
Rayonier Advanced Materials Inc. to Report Q3, 2025 Results on Nov 04, 2025 Rayonier Advanced Materials Inc. announced that they will report Q3, 2025 results After-Market on Nov 04, 2025 Duyuru • Oct 06
Rayonier Advanced Materials Inc. Announces the Introduction of its Enhanced Freezer Application for Folding Carton Board Rayonier Advanced Materials Inc. announced the introduction of its Enhanced Freezer Application for folding carton board, purpose-built to meet the packaging needs of the frozen food sector. This enhancement builds on RYAM's trusted folding grade, ensuring converters and brand owners have a proven, reliable solution for frozen meals packaging. Developed at RYAM's Temiscaming facility, this advancement equips Kallima's folding grade with the durability and performance required for cold-chain distribution. Engineered to withstand temperatures as low as -18degC (0degF), it maintains structural integrity and resists delamination in freezer conditions. Its natural resistance to moisture and condensation--without coatings or plastic extrusion--delivers cost efficiency, ease of converting, and sustainability benefits. Key Benefits for Folding Box Converters: Reliable Cold Performance - Withstands industry-standard freezer conditions without compromise. Moisture-Resistant Design - Performs in high-humidity environments without added treatments. No Coatings Required - Simplifies converting and reduces costs by eliminating extrusions. Versatile Usage - Ideal for a range of frozen food applications, from ready meals to protein trays. Premium Print Surface - Supports high-quality graphics and consistent converting results. Sustainable Solution - Made from responsibly sourced, certified forest fiber. This innovation comes as the frozen food market continues to grow worldwide, driven by consumer demand for convenience and extended shelf life. With the Enhanced Freezer Application, RYAM provides packaging manufacturers with a solution that safeguards product integrity while delivering on sustainability and operational efficiency. Duyuru • Sep 20
Rayonier Advanced Materials Inc. Announces Executive Changes, Effective October 10, 2025 On September 19, 2025, Rayonier Advanced Materials Inc. (the Company") announced that Gabriela Garcia, the Company's Chief Accounting Officer and Vice President, Corporate Controller, has resigned, effective October 10, 2025. Ms. Garcia has served as the Company's Chief Accounting Officer since September 1, 2020. Ms. Garcia's resignation was not the result of any disagreement with the Company on any matter relating to its operations, policies, or practices. On September 19, 2025, the Company also announced that Jared Rollins has been appointed Chief Accounting Officer and Vice President, Corporate Controller, effective October 10, 2025. Mr. Rollins, age 48, joined Rayonier Inc. in October 2006 as Manager of Tax Reporting and Planning. He was promoted to Senior Manager in January 2012 and, following the Company's 2014 spinoff from Rayonier Inc., became Director of Tax Reporting and Planning, a role he held until September 1, 2020, when he was elected Vice President, Financial Planning and Analysis. Prior to joining Rayonier Inc., Mr. Rollins served as a Senior Consultant in Real Estate Tax at Deloitte & Touche LLP and as a Senior Tax Researcher at Wells Real Estate Funds. He holds a Master of Accounting degree with a concentration in Taxation from the University of Florida and a bachelor's degree in Secondary Education from Toccoa Falls College. He is also a Certified Public Accountant (CPA). Recent Insider Transactions • Aug 15
President recently bought US$252k worth of stock On the 12th of August, De Lyle Bloomquist bought around 54k shares on-market at roughly US$4.71 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. De Lyle has been a buyer over the last 12 months, purchasing a net total of US$502k worth in shares. New Risk • Aug 07
New major risk - Revenue and earnings growth Earnings have declined by 31% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.3x net interest cover). Earnings have declined by 31% per year over the past 5 years. Reported Earnings • Aug 06
Second quarter 2025 earnings: EPS and revenues miss analyst expectations Second quarter 2025 results: US$5.47 loss per share (down from US$0.12 profit in 2Q 2024). Revenue: US$340.0m (down 19% from 2Q 2024). Net loss: US$366.0m (down US$374.2m from profit in 2Q 2024). Revenue missed analyst estimates by 12%. Earnings per share (EPS) also missed analyst estimates significantly. Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 58 percentage points per year, which is a significant difference in performance. Duyuru • Jul 24
Rayonier Advanced Materials Inc. to Report Q2, 2025 Results on Aug 05, 2025 Rayonier Advanced Materials Inc. announced that they will report Q2, 2025 results After-Market on Aug 05, 2025 Recent Insider Transactions • May 21
President recently bought US$250k worth of stock On the 16th of May, De Lyle Bloomquist bought around 63k shares on-market at roughly US$3.95 per share. This transaction amounted to 15% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was De Lyle's only on-market trade for the last 12 months. Reported Earnings • May 07
First quarter 2025 earnings: EPS and revenues miss analyst expectations First quarter 2025 results: US$0.48 loss per share (further deteriorated from US$0.024 loss in 1Q 2024). Revenue: US$356.0m (down 8.2% from 1Q 2024). Net loss: US$32.0m (loss widened US$30.4m from 1Q 2024). Revenue missed analyst estimates by 7.5%. Earnings per share (EPS) also missed analyst estimates significantly. Revenue is forecast to grow 3.1% p.a. on average during the next 2 years, compared to a 4.1% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Duyuru • Apr 29
Rayonier Advanced Materials Inc. to Report Q1, 2025 Results on May 06, 2025 Rayonier Advanced Materials Inc. announced that they will report Q1, 2025 results After-Market on May 06, 2025 Duyuru • Mar 24
Rayonier Advanced Materials Inc., Annual General Meeting, May 14, 2025 Rayonier Advanced Materials Inc., Annual General Meeting, May 14, 2025. Recent Insider Transactions Derivative • Mar 06
President exercised options and sold US$245k worth of stock On the 1st of March, De Lyle Bloomquist exercised options to acquire 32k shares at no cost and sold these for an average price of US$7.70 per share. This trade did not impact their existing holding. For the year to December 2018, De Lyle's total compensation was 27% salary and 73% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2024, De Lyle has owned 176.89k shares directly. Company insiders have collectively sold US$586k more than they bought, via options and on-market transactions in the last 12 months. Duyuru • Feb 20
Rayonier Advanced Materials Inc. to Report Q4, 2024 Results on Mar 05, 2025 Rayonier Advanced Materials Inc. announced that they will report Q4, 2024 results After-Market on Mar 05, 2025 Duyuru • Feb 04
Rayonier Advanced Materials Inc. Provides Revenue Guidance for the Year 2025 Rayonier Advanced Materials Inc. provided revenue guidance for the year 2025. For the year 2025, the company’s revenue is expected to be flat to 2024 levels. Price Target Changed • Jan 14
Price target increased by 32% to US$12.50 Up from US$9.50, the current price target is an average from 2 analysts. New target price is 69% above last closing price of US$7.40. Stock is up 77% over the past year. The company is forecast to post a net loss per share of US$0.47 next year compared to a net loss per share of US$1.57 last year. Duyuru • Nov 13
Rayonier Advanced Materials Inc. announced that it has received €30 million in funding from Swen Capital Partners, SA Rayonier Advanced Materials Inc. announced that it has received €30 million in a round of funding on November 12, 2024. the transaction included participation from new investor, SWEN Impact Fund for Transition 3, a fund managed by Swen Capital Partners, SA, for a 20% stake in its newly formed subsidiary, RYAM BioNova S.A.S. The company has issued preferred shares in the transaction. Duyuru • Oct 29
Rayonier Advanced Materials Inc. announced that it has received $700 million in funding Rayonier Advanced Materials Inc. announced that it has received aggregate principal amount of $700 in a round of funding on October 29, 2024. The company has issued secured term loan in the transaction. The transaction was led by funds managed by returning investor, Oaktree Capital Management, L.P., and included participation from new lenders, Silver Point Capital, L.P., Blue Torch Capital LP. The term loan will initially accrue interest at an annual rate equal to three-month Term SOFR plus an initial spread of 7%. The term loan will mature in five years. The company may, with modest call premiums, voluntarily prepay the Term Loan, subject to an additional make-whole premium for the first eighteen months, followed by a 2 percent premium during the next six months and a 1 percent premium for the twelve months thereafter. The company may prepay the Term Loan at par after 36 months. Duyuru • Oct 24
Rayonier Advanced Materials Inc. to Report Q3, 2024 Results on Nov 05, 2024 Rayonier Advanced Materials Inc. announced that they will report Q3, 2024 results After-Market on Nov 05, 2024 Duyuru • Oct 14
Rayonier Advanced Materials Inc. Provides Update on Estimate of Loss from Fire At Its Jesup Plant Rayonier Advanced Materials Inc. reported that an isolated fire occurred at its Jesup, Georgia facility on October 11 at approximately 6 p.m. during planned maintenance activity. While the Company continues to assess the financial cost of the incident, the EBITDA impact is currently expected to be in the range of $15 million to $20 million, subject to any potential insurance recovery. The Company will provide further updates on its third quarter earnings call in early November. Duyuru • Sep 11
Rayonier Advanced Materials Inc. Announces Board and Committee Changes Charles E. Adair tendered his resignation from the Board of Directors (the “Board”) of Rayonier Advanced Materials Inc. (the “Company”) effective on September 8, 2024. Mr. Adair’s resignation is due to personal reasons. Effective September 9, 2024, the Company’s Board elected Eric M. Bowen as a Class I independent director of the Company to serve until the 2027 annual meeting of the stockholders of the Company and thereafter until his successor has been duly elected and qualified, or until his earlier death, resignation or removal. Effective September 9, 2024, Mr. Bowen was also appointed to each of the Audit Committee and the Sustainability Committee of the Board. Mr. Bowen currently serves on the Advisory Board of Terviva Inc., a private California company developing a novel tree crop for biofuel, feed and food markets. He held a number of roles at Renewable Energy Group Inc. from 2010 through its sale in June 2022. He most recently served as General Counsel, Corporate Secretary, and Vice President of Strategy, from April 2020 through June 2022, where he was instrumental in growing the company’s renewable diesel business and completing the sale of REGI to Chevron Corporation. Prior to that, in his capacity as Vice President, Corporate Business Development & Legal Affairs from January 2013 to April 2020, Mr. Bowen positioned the company into emerging decarbonization markets, including renewable diesel. He also served as head of the REGI Life Sciences business unit from January 2014 until its sale in May 2019. Prior to his tenure with REGI, Mr. Bowen served as Founder, President and CEO of Tellurian Biodiesel Inc., a leading California waste-based, low-carbon fuel company that was acquired by REGI in 2010. Mr. Bowen has served as a member of various boards of directors during his career, including most recently with Forge Hydrocarbons from November 2013 to October 2022, and with Hydrogen Works from December 2021 through July 2024. He holds a J.D. from the University of California, Berkeley and a B.A. from the University of Oregon Honors College. Major Estimate Revision • Aug 14
Consensus EPS estimates fall by 118%, revenue upgraded The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from US$1.62b to US$1.64b. Forecast EPS reduced from -US$0.34 to -US$0.74 per share. Chemicals industry in the US expected to see average net income growth of 40% next year. Consensus price target up from US$7.00 to US$9.00. Share price was steady at US$7.44 over the past week. New Risk • Aug 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (0.4x net interest cover). Minor Risk Share price has been volatile over the past 3 months (7.7% average weekly change). Reported Earnings • Aug 07
Second quarter 2024 earnings: EPS and revenues exceed analyst expectations Second quarter 2024 results: EPS: US$0.12 (up from US$0.24 loss in 2Q 2023). Revenue: US$419.0m (up 8.7% from 2Q 2023). Net income: US$8.00m (up US$23.6m from 2Q 2023). Profit margin: 1.9% (up from net loss in 2Q 2023). Revenue exceeded analyst estimates by 4.2%. Earnings per share (EPS) also surpassed analyst estimates. Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Price Target Changed • Jul 30
Price target increased by 27% to US$7.00 Up from US$5.50, the current price target is an average from 2 analysts. New target price is 12% above last closing price of US$6.27. Stock is up 33% over the past year. The company is forecast to post a net loss per share of US$0.34 next year compared to a net loss per share of US$1.57 last year. Duyuru • Jul 24
Rayonier Advanced Materials Inc. to Report Q2, 2024 Results on Aug 06, 2024 Rayonier Advanced Materials Inc. announced that they will report Q2, 2024 results at 4:00 PM, US Eastern Standard Time on Aug 06, 2024 Duyuru • May 01
Rayonier Advanced Materials Inc. Announces to Suspend Temiscaming High Purity Cellulose Plant Operations for an Indefinite Period Rayonier Advanced Materials Inc. announced that, effective July 2, 2024, it will suspend operations at its Temiscaming High Purity Cellulose (HPC) plant for an indefinite period. As previously communicated, the Company remains committed to operating its assets profitably. Given current market conditions and high capital and fixed costs associated with the HPC plant, this decision will help mitigate the plant's ongoing operating losses and improve the Company's consolidated free cash flow. Today's announcement is aligned with the Company's focus on improving its balance sheet, leverage position and overall financial performance toward execution of its long-term growth strategy. The suspension, which will be carried out in a safe and environmentally sound manner, will result in a reduction of RYAM's annual global HPC production. The Temiscaming HPC facility has an annual production capacity of approximately 150,000 metric tons, with roughly 30% historically dedicated to specialty cellulose materials. The Company will be working directly with its customers to support their specialty cellulose needs in both the short- and long-term. This announcement will result in approximately 275 layoffs. This decision does not affect RYAM's paperboard and high-yield pulp plants located adjacent to the Temiscaming HPC plant. These two plants, which are part of an ongoing sales process announced last October, remain competitive and will continue to operate at full capacity. Duyuru • Apr 26
Rayonier Advanced Materials Inc. to Report Q1, 2024 Results on May 07, 2024 Rayonier Advanced Materials Inc. announced that they will report Q1, 2024 results After-Market on May 07, 2024 Duyuru • Apr 17
Rayonier Advanced Materials Inc.'s Tartas Plant Successfully Ships Inaugural Truckload of 2G Bioethanol Rayonier Advanced Materials Inc. announced the successful shipment of first production of 2G bioethanol from Tartas plant, following two years of rigorous research, development, construction, and planning. Duyuru • Mar 30
Rayonier Advanced Materials Inc., Annual General Meeting, May 15, 2024 Rayonier Advanced Materials Inc., Annual General Meeting, May 15, 2024, at 17:30 US Eastern Standard Time. Location: DoubleTree 1201 Riverplace Boulevard, Jacksonville Florida United States Agenda: To Elect the Board’s three nominees for Class I directors for terms expiring in 2027; to Approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to declassify the Board of Directors; to Approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to eliminate the supermajority voting provision; to Approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to allow for exculpation of officers as permitted by Delaware law; to Approve, in a non-binding vote, the compensation of our named executive officers as disclosed in the accompanying Proxy Statement; and to discuss other matters. Reported Earnings • Feb 28
Full year 2023 earnings: EPS misses analyst expectations Full year 2023 results: US$1.57 loss per share (further deteriorated from US$0.43 loss in FY 2022). Revenue: US$1.64b (down 4.3% from FY 2022). Net loss: US$102.0m (loss widened 273% from FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 128%. Revenue is forecast to grow 3.1% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 30% per year, which means it is performing significantly worse than earnings. Duyuru • Feb 14
Rayonier Advanced Materials Inc. to Report Q4, 2023 Results on Feb 27, 2024 Rayonier Advanced Materials Inc. announced that they will report Q4, 2023 results After-Market on Feb 27, 2024 Duyuru • Nov 08
Rayonier Advanced Materials Inc. Provides Earnings Guidance for the Year 2023 Rayonier Advanced Materials Inc. provided earnings guidance for the year 2023. For the year, the company expects loss from continuing operations to be approximately $45 million. Duyuru • Oct 26
Rayonier Advanced Materials Inc. to Report Q3, 2023 Results on Nov 07, 2023 Rayonier Advanced Materials Inc. announced that they will report Q3, 2023 results After-Market on Nov 07, 2023 Duyuru • Oct 07
Rayonier Advanced Materials Inc. to Temporarily Idle Production At Its Paperboard and High-Yield Pulp Operations Rayonier Advanced Materials Inc. is announcing that in order to optimize inventory levels and address lower-than-anticipated demand, its Témiscaming Paperboard operation and one of its High-Yield Pulp lines will be idled for 3 weeks, beginning on October 7, 2023. Customer orders will not be affected. Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to US$3.49, the stock trades at a trailing P/E ratio of 28.8x. Average forward P/E is 14x in the Chemicals industry in the US. Total returns to shareholders of 14% over the past three years. Valuation Update With 7 Day Price Move • Sep 07
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to US$2.98, the stock trades at a trailing P/E ratio of 24.6x. Average forward P/E is 14x in the Chemicals industry in the US. Total loss to shareholders of 19% over the past three years. Valuation Update With 7 Day Price Move • Aug 16
Investor sentiment deteriorates as stock falls 30% After last week's 30% share price decline to US$2.99, the stock trades at a trailing P/E ratio of 24.6x. Average forward P/E is 14x in the Chemicals industry in the US. Total loss to shareholders of 1.6% over the past three years. Major Estimate Revision • Aug 16
Consensus EPS estimates fall by 121% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from US$1.78b to US$1.73b. Losses expected to increase from US$0.14 per share to US$0.31. Chemicals industry in the US expected to see average net income growth of 17% next year. Consensus price target down from US$5.50 to US$4.75. Share price fell 30% to US$2.99 over the past week. New Risk • Aug 10
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Earnings are forecast to decline by an average of 128% per year for the foreseeable future. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (2.1% increase in shares outstanding). Price Target Changed • Aug 10
Price target decreased by 17% to US$4.75 Down from US$5.70, the current price target is an average from 2 analysts. New target price is 46% above last closing price of US$3.25. Stock is down 34% over the past year. The company is forecast to post a net loss per share of US$0.31 next year compared to a net loss per share of US$0.43 last year. Reported Earnings • Aug 09
Second quarter 2023 earnings: EPS and revenues miss analyst expectations Second quarter 2023 results: US$0.24 loss per share (improved from US$0.39 loss in 2Q 2022). Revenue: US$385.0m (down 3.6% from 2Q 2022). Net loss: US$16.0m (loss narrowed 36% from 2Q 2022). Revenue missed analyst estimates by 3.2%. Earnings per share (EPS) also missed analyst estimates by 117%. Revenue is expected to decline by 7.4% p.a. on average during the next 2 years, while revenues in the Chemicals industry in the US are expected to grow by 4.3%. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 09
Second quarter 2023 earnings: EPS and revenues miss analyst expectations Second quarter 2023 results: US$0.24 loss per share (improved from US$0.39 loss in 2Q 2022). Revenue: US$385.0m (down 3.6% from 2Q 2022). Net loss: US$16.0m (loss narrowed 36% from 2Q 2022). Revenue missed analyst estimates by 3.2%. Earnings per share (EPS) also missed analyst estimates by 117%. Revenue is expected to decline by 7.4% p.a. on average during the next 2 years, while revenues in the Chemicals industry in the US are expected to grow by 4.3%. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Duyuru • Aug 09
Rayonier Advanced Materials Inc. Provides Earnings Guidance for the Year 2023 Rayonier Advanced Materials Inc. provided earnings guidance for the year 2023. For the year, the company expects loss from continuing operations to be approximately $17 million to $2 million. Duyuru • Jul 26
Rayonier Advanced Materials Inc. to Report Q2, 2023 Results on Aug 08, 2023 Rayonier Advanced Materials Inc. announced that they will report Q2, 2023 results After-Market on Aug 08, 2023 Board Change • Jun 02
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 4 highly experienced directors. Independent Director Chas Eggert was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Recent Insider Transactions • May 16
Insider recently bought US$93k worth of stock On the 12th of May, Joshua Hicks bought around 20k shares on-market at roughly US$4.63 per share. This transaction amounted to 40% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought US$198k more in shares than they have sold in the last 12 months. Major Estimate Revision • May 16
Consensus EPS estimates fall by 30%, revenue upgraded The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from US$1.78b to US$1.81b. Forecast EPS reduced from -US$0.10 to -US$0.13 per share. Chemicals industry in the US expected to see average net income growth of 15% next year. Consensus price target of US$5.70 unchanged from last update. Share price fell 16% to US$4.63 over the past week. Reported Earnings • May 10
First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind First quarter 2023 results: EPS: US$0.031 (up from US$0.38 loss in 1Q 2022). Revenue: US$467.0m (up 33% from 1Q 2022). Net income: US$2.00m (up US$26.4m from 1Q 2022). Profit margin: 0.4% (up from net loss in 1Q 2022). Revenue exceeded analyst estimates by 11%. Earnings per share (EPS) missed analyst estimates by 50%. Revenue is expected to decline by 3.8% p.a. on average during the next 2 years, while revenues in the Chemicals industry in the US are expected to grow by 4.7%. Over the last 3 years on average, earnings per share has increased by 35% per year whereas the company’s share price has increased by 33% per year. Duyuru • May 10
Rayonier Advanced Materials Inc. Provides Earnings Guidance for the Year 2023 Rayonier Advanced Materials Inc. provided earnings guidance for the year 2023. For the year, the company expects income from continuing operations to be between negative $8 million to $12 million. Price Target Changed • Apr 25
Price target decreased by 8.1% to US$5.70 Down from US$6.20, the current price target is an average from 2 analysts. New target price is 5.9% above last closing price of US$5.38. Stock is up 4.5% over the past year. The company is forecast to post a net loss per share of US$0.10 next year compared to a net loss per share of US$0.43 last year. Major Estimate Revision • Mar 22
Consensus EPS estimates upgraded to US$0.10 loss, revenue downgraded The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from US$1.86b to US$1.82b. 2023 losses expected to reduce from -US$0.35 to -US$0.10 per share. Chemicals industry in the US expected to see average net income growth of 11% next year. Consensus price target up from US$6.00 to US$6.20. Share price was steady at US$6.40 over the past week. Major Estimate Revision • Mar 08
Consensus revenue estimates increase by 14% The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from US$1.64b to US$1.86b. EPS estimate unchanged from -US$0.35 at last update. Chemicals industry in the US expected to see average net income growth of 15% next year. Consensus price target of US$6.00 unchanged from last update. Share price fell 4.9% to US$7.98 over the past week. 
